| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/09/2003 | WO2002000696A3 Herbicide target genes and methods |
| 01/09/2003 | WO2002000618A3 Progesterone receptor-regulated gene expression and methods related thereto |
| 01/09/2003 | WO2002000017A3 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 01/09/2003 | WO2001098510A3 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
| 01/09/2003 | WO2001098480A3 Promoters for regulation of plant gene expression |
| 01/09/2003 | WO2001098351A3 G-protein coupled receptors |
| 01/09/2003 | WO2001097828A3 Rhob as a suppressor of cancer cell growth and cell transformation |
| 01/09/2003 | WO2001092512A3 Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides |
| 01/09/2003 | WO2001092463A3 Method of rna cleavage |
| 01/09/2003 | WO2001090390A9 Use of baculovirus vectors in gene therapy |
| 01/09/2003 | WO2001081376A3 Apo-ai/aii peptide derivatives |
| 01/09/2003 | WO2001079489A8 39228, a human alcohol dehydrogenase and uses therefor |
| 01/09/2003 | WO2001079480A9 Albumin fusion proteins |
| 01/09/2003 | WO2001075173A3 β 2 ADRENERGIC POLYMORPHISM DETECTION |
| 01/09/2003 | WO2001074846A3 Peptides mimicking the biological activity of steroid hormones and their uses |
| 01/09/2003 | WO2001073127A3 Improved invasion assay |
| 01/09/2003 | WO2001070776A3 Nimr compositions and their methods of use |
| 01/09/2003 | WO2001068841A3 Human dcc-like proteins |
| 01/09/2003 | WO2001066801A3 Very low density lipoprotein receptor polymorphisms and uses therefor |
| 01/09/2003 | WO2001066779A3 Arabitol or ribitol as positive selectable markers |
| 01/09/2003 | WO2001066764A9 16835, a human phospholipase c and uses thereof |
| 01/09/2003 | WO2001066759A9 26886, a novel carnitine acyltransferase family member and uses therefor |
| 01/09/2003 | WO2001066598A9 Chemoattractant receptor characterization and cell selection materials and methods and chemokine receptor ccr11 materials and methods |
| 01/09/2003 | WO2001057278A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human hela cells or other human cervical epithelial cells |
| 01/09/2003 | WO2001057276A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow |
| 01/09/2003 | WO2001057267A9 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 01/09/2003 | WO2001055411A9 Human sulfatases |
| 01/09/2003 | WO2001055336A9 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/09/2003 | WO2001055333A9 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 01/09/2003 | WO2001053504A9 Replication deficient adenovirus vectors |
| 01/09/2003 | US20030009785 Plant cytoprotective genes and methods of using same |
| 01/09/2003 | US20030009784 Expression of trehalose biosynthetic genes in plants |
| 01/09/2003 | US20030009783 Genetic engineering of plant chloroplasts |
| 01/09/2003 | US20030009782 Compositions and methods for fumonisin detoxification |
| 01/09/2003 | US20030009781 Animal model for use in the treatment of pain and anxiety disorders |
| 01/09/2003 | US20030009780 Animal models for use as tools in the diagnosis, prevention and treatment of nervous system and psychological disorders |
| 01/09/2003 | US20030009779 Transgenic mice containing ubiquitin enzyme gene disruptions |
| 01/09/2003 | US20030009778 Expresion vector for use in the generation of animal for evaluating bone and kidney disorders |
| 01/09/2003 | US20030009777 Using galanin agonist in the generation of medicament for the treatment of nerve damage |
| 01/09/2003 | US20030009776 Transgenic animal; for use as model in the treatment of cancer |
| 01/09/2003 | US20030009774 Trangenic rodent for use as model in evaluation of xenobiotics |
| 01/09/2003 | US20030009296 Database and system for storing, comparing and displaying genomic information |
| 01/09/2003 | US20030009026 Insertion sequence element derived from ralstonia solanacearum |
| 01/09/2003 | US20030009024 46584, a human transporter family member and uses therefor |
| 01/09/2003 | US20030009022 Methods and compositions for identifying receptor effectors |
| 01/09/2003 | US20030009021 Novel human proteases and polynucleotides encoding the same |
| 01/09/2003 | US20030009020 Gene originating in human chondrocyte |
| 01/09/2003 | US20030009019 Novel telomerase |
| 01/09/2003 | US20030009018 Novel hemopoietin receptor protein, NR12 |
| 01/09/2003 | US20030009017 For diagnosis and therapy of cancer or aberrant cellular proliferation and/or differentiation, immune disorders, heart disorders, cardiovascular disorders, including endothelial cell disorders, hematopoietic and blood vessel disorder |
| 01/09/2003 | US20030009011 Novel inositol polyphosphate kinase genes and uses thereof |
| 01/09/2003 | US20030009010 As vaccines for therapy and prophylaxis of Haemophilus influenzae infection |
| 01/09/2003 | US20030008840 Methods for treating cancer |
| 01/09/2003 | US20030008839 Use of a dimethyldialkylammonium salt as an adjuvant for a nucleic acid vaccine |
| 01/09/2003 | US20030008838 Method of increasing endogenous leptin production |
| 01/09/2003 | US20030008837 Therapy |
| 01/09/2003 | US20030008836 Eukaryotic gene expression cassette and uses thereof |
| 01/09/2003 | US20030008824 Stimulation of vascularization with VEGF-B |
| 01/09/2003 | US20030008823 For determining ligand binding, detecting expression, drug screening, and treatment involving the human 5-HT1F receptor |
| 01/09/2003 | US20030008820 Methods and products related to FGF dimerization |
| 01/09/2003 | US20030008816 Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| 01/09/2003 | US20030008815 For diagnosis and therapy of immune related disease in mammals, including humans; tumor therapy |
| 01/09/2003 | US20030008414 Water-soluble luminescent quantum dots and biomolecular conjugates thereof and related compositions and methods of use |
| 01/09/2003 | US20030008399 Controlling viral replication or gene expression in a cell; obtain cell infected with virus, transform with nucleotide sequence expressng preferential replicases, monitor viral gene expression |
| 01/09/2003 | US20030008398 Nucleotide sequences coding polypeptide for use in the treatment of autoimmune and inflammatory diseases |
| 01/09/2003 | US20030008391 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008390 Genetically engineered cell for use in the generation of viral vector for use in gene therapy |
| 01/09/2003 | US20030008380 Gnetically engineered cells for use in the generation of heterologous proteins |
| 01/09/2003 | US20030008376 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008375 Generation of preferential adenoviral expression vector; obtain cells, infect with virus, harvest and lyse cell, recover vectors |
| 01/09/2003 | US20030008374 Methods and compositions relating to improved lentiviral vectors and their applications |
| 01/09/2003 | US20030008372 Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon |
| 01/09/2003 | US20030008369 Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases |
| 01/09/2003 | US20030008368 Serine O-acetytransferase |
| 01/09/2003 | US20030008366 Polypeptide for use in the treatment of inflammation |
| 01/09/2003 | US20030008365 Nucleotide sequences coding polypeptides for use in human therapeutics, diagnostics and pharmacology |
| 01/09/2003 | US20030008363 Gram-positive bacterium for use in the generation of ethanol |
| 01/09/2003 | US20030008358 Method of producing L-serine by fermentation |
| 01/09/2003 | US20030008357 Polypeptide for use in the treatment of inflammation, rheumatoid arritis, psoriasis, and diabetic retinopathy |
| 01/09/2003 | US20030008354 Peptide for use in the diagnosis and treatment of parkinson's, cancer and developmental defects |
| 01/09/2003 | US20030008351 Nucleotide sequences coding polypeptide for use in the treatment of heart defects |
| 01/09/2003 | US20030008350 14273 receptor, a novel G-protein coupled receptor |
| 01/09/2003 | US20030008349 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/09/2003 | US20030008344 T1R taste receptors and genes encoding same |
| 01/09/2003 | US20030008342 Vaccine for use in the treatment and prevention of cancer, autoimmune disease, human viral infections |
| 01/09/2003 | US20030008337 Analytical system based upon spore germination |
| 01/09/2003 | US20030008334 Protein for use in the diagnosis, prevention and treatment of cancer |
| 01/09/2003 | US20030008331 Directed evolution biosensors |
| 01/09/2003 | US20030008330 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cancer and autoimmune disease |
| 01/09/2003 | US20030008329 Receptor protein for use in the treatment of stomach ulcer, diabetes, alzheimer's and brain disorders |
| 01/09/2003 | US20030008321 Antibody for use as tool in immunoassay |
| 01/09/2003 | US20030008320 Isolation of nucleic acids |
| 01/09/2003 | US20030008319 Sequence based screening |
| 01/09/2003 | US20030008318 Determination of the number of copies of a preferential nucleotide sequence in sample; obtain sample, incubate with solid support and probe, detecting the amount of binding of the first and second labelled complementary |
| 01/09/2003 | US20030008317 Detection of modulator of translation; generate translation reaction mixture, incubate with modulator, detect polypeptide generation, generation of polypeptides indicates translation has not been inhibited |
| 01/09/2003 | US20030008316 Anthraquinone and its derivatives |
| 01/09/2003 | US20030008315 Ribozyme-encoding DNA and a composition containing an oligonucleotide substrate and a method for measuring transcription rates |
| 01/09/2003 | US20030008311 Histone-like protein |
| 01/09/2003 | US20030008307 Methods for diagnosing activated protein C resistance associated with a factor V genetic mutation and compositions thereof |
| 01/09/2003 | US20030008306 Nucleotide sequence for use in the generation of preferential oligomers |